SCHEMBL14412261

SCHEMBL14412261

OCc1ccccc1Sc1ccccc1CNc1nc(NC2(CO)CCSCC2)c2ccccc2n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.40
▸ KDM4E B2RXH2 3/20 0.40
▸ KMT2A Q03164 3/20 0.40
▸ NPSR1 Q6W5P4 2/20 0.40
▸ ALDH1A1 P00352 2/20 0.40
▸ LMNA P02545 1/20 0.40
▸ PKM P14618 1/20 0.40
▸ UBE2N P61088 1/20 0.40
▸ RCE1 Q9Y256 1/20 0.40
▸ RAD52 P43351 2/20 0.38
▸ HTT P42858 3/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ TAAR1 Q96RJ0 2/20 0.36
▸ POLB P06746 1/20 0.36
▸ BCHE P06276 4/20 0.35
▸ ACHE P22303 4/20 0.35
▸ APP P05067 3/20 0.35
▸ LATS1 O95835 2/20 0.34
▸ LATS2 Q9NRM7 2/20 0.34
▸ NLRP3 Q96P20 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14412274 0.89 LMNA (0.40) MAPTKDM4EKMT2ANPSR1ALDH1A1
SCHEMBL14256702 0.76 PIK3R1 (0.43) MAPTKDM4EKMT2ANPSR1ALDH1A1
SCHEMBL14256722 0.76 CYP3A4 (0.38) MAPTKDM4EKMT2ANPSR1ALDH1A1
SCHEMBL14256641 0.75 RAD52 (0.44) MAPTKDM4EKMT2ANPSR1ALDH1A1
SCHEMBL14256694 0.75 RAD52 (0.44) MAPTKDM4EKMT2ANPSR1ALDH1A1
SCHEMBL14256950 0.75 BCHE (0.52) MAPTKDM4EKMT2ANPSR1ALDH1A1
SCHEMBL14256444 0.75 MERTK (0.53) KMT2ABCHEACHEAPPMEN1
SCHEMBL14256699 0.74 MERTK (0.52) KMT2ABCHEACHEAPPMEN1
SCHEMBL14412234 0.74 GBA1 (0.49) MAPTKDM4EKMT2ANPSR1ALDH1A1
SCHEMBL14266760 0.74 PDE5A (0.55) MAPTKDM4EKMT2ANPSR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070213319-A1 Modulators of hepatocyte growth factor/c-Met activity ANGION BIOMEDICA CORPORATION (US) 2007-09-13 — — US disclosed
US-20070213319-A1 Modulators of hepatocyte growth factor/c-Met activity ANGION BIOMEDICA CORPORATION (US) 2007-09-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070213319-A1 Modulators of hepatocyte growth factor/c-Met activity HGF, MET, HDGF MAPT 3385/4885KDM4E 2587/4885KMT2A 1886/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback